nVerses Capital’s IDEAYA Biosciences IDYA Stock Holding History

nVerses Capital’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$4.39K	–	1100
2024 Q1	$4.39K	Buy	+100	New	+$4.3K	0.01%	592

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

nVerses Capital's IDYA Position: Q2 2024 in Review

nVerses Capital sold out of IDEAYA Biosciences (IDYA) in Q2 2024, closing a stake of 100 shares — an estimated $4.39K sold.

nVerses Capital first reported a position in IDYA in Q1 2024 and held it in 1 quarter. The position peaked at $4.39K in Q1 2024. 199 funds tracked by Wall St. Rank hold IDYA as of Q2 2024.

nVerses Capital reported no remaining IDEAYA Biosciences position as of Q2 2024 after selling out during the quarter.
nVerses Capital sold 100 IDEAYA Biosciences shares in Q2 2024, an estimated $4.39K.
nVerses Capital first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 1 quarter.
nVerses Capital's IDEAYA Biosciences position peaked at $4.39K in Q1 2024.
199 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.